Sunday, May 15, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

DoD PREPARE Program Aims to Boost the Body’s Defense Against Health Threats

by Global Biodefense Staff
July 3, 2018
DAPRA PREPARE Program - Gene modulation to protect against CBR threats

Credit: DARPA

Influenza pandemics, organophosphate poisoning, opioid overdose, and exposure to ionizing radiation are representative of the broad spectrum of biological, chemical, and radiological (CBR) threats that can significantly impact public health and national security. These seemingly disparate threats share a common challenge: despite decades of laboratory experimentation and significant research investment, broad-acting, longer-lived, and effective medical countermeasures (MCMs) remain elusive.

The Defense Department’s new PReemptive Expression of Protective Alleles and Response Elements (PREPARE) program aims to develop programmable gene modulators for humans that can provide medical countermeasures and prophylaxes to better protect against such CBR threats.

Managed by the Defense Advanced Research Projects Agency (DARPA), the PREPARE program aims to temporarily and reversibly tune gene expression to bolster the body’s defenses against—or directly neutralize—a given threat. It will focus on four key health challenges as proofs of concept:

  • Influenza Viral Infection
  • Opioid Overdose
  • Organophosphate Poisoning
  • Exposure to Gamma Radiation

Proposed research should investigate disruptive approaches for the identification of gene targets that, when modulated, confer protection or resistance against these threats; the development of novel tools to modulate the activity of target genes; and the generation of clinical formulations that enable delivery to the appropriate cells and tissues in vivo.

The integration of these approaches into a platform that can produce novel medical countermeasures MCMs should enable a specific, potent, safe, and transient approach for directly modulating the activity of target genes to limit the damaging and potentially fatal consequences of a broad range of threats to warfighters, first responders, and civilian populations.

Additional details are available on FedBizOps under Solicitation Number: HR001118S0037.

Tags: BAAChemical WeaponsDARPAInfluenzaOpioid EpidemicRadiation

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents
CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

April 11, 2022
Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses
Pathogens

Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses

April 11, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC